The inhibitory effect of the catechin structure on advanced glycation end product formation in alcoholic media

Advanced glycation end products (AGEs) and their important intermediate products (α-dicarbonyl compounds) that are generated by the Maillard reaction are closely related to diabetes. Our study first investigated the mechanisms of the anti-glycation effects of epicatechin (EC), (-)-epicatechin gallate (ECG), (-)-epigallocatechin (EGC), and (-)-epigallocatechin gallate (EGCG) in an alcoholic environment. The results showed that catechins played an important role in the inhibition of AGE formation, and the effect of EC was the best. Their corresponding mechanisms included total antioxidant capacity (TAOC), 1,1-diphenyl-2-picrylhydrazyl (DPPH) scavenging ability, trapping of methylglyoxal (MGO), protection of the protein structure, and inhibition of the activities of α-amylase, α-glucosidase, and β-glucosidase, which were consistent with the study of molecular docking. This study will offer a theoretical basis for the applications of different types of catechins to alcoholic beverages as natural AGE formation inhibitors.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Food & function - 11(2020), 6 vom: 24. Juni, Seite 5396-5408

Sprache:

Englisch

Beteiligte Personen:

Wu, Qian [VerfasserIn]
Tang, Shimiao [VerfasserIn]
Zhang, Liang [VerfasserIn]
Xiao, Jinsong [VerfasserIn]
Luo, Qing [VerfasserIn]
Chen, Yuanyuan [VerfasserIn]
Zhou, Mengzhou [VerfasserIn]
Feng, Nianjie [VerfasserIn]
Wang, Chao [VerfasserIn]

Links:

Volltext

Themen:

1,1-diphenyl-2-picrylhydrazyl
2L9GJK6MGN
722KLD7415
8R1V1STN48
92587OVD8Z
Alpha-Amylases
Alpha-Glucosidases
Antioxidants
BQM438CTEL
Biphenyl Compounds
Catechin
DFD3H4VGDH
Diphenyl
EC 3.2.1.-
EC 3.2.1.1
EC 3.2.1.20
Epicatechin gallate
Epigallocatechin gallate
Gallocatechol
Glucosidases
Glycation End Products, Advanced
HEJ6575V1X
Journal Article
Picrates
Pyruvaldehyde

Anmerkungen:

Date Completed 26.04.2021

Date Revised 26.04.2021

published: Print

Citation Status MEDLINE

doi:

10.1039/c9fo02887k

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM310498724